SmartWinnr launches medical simulation center of excellence to advance AI readiness in pharma and medtech

SmartWinnr, a sales enablement and readiness platform, on Thursday announced the launch of a specialized medical simulation center of excellence to strengthen the accuracy, relevance and compliance readiness of its AI-driven learning solutions for the pharmaceutical and medtech sectors. The company headquartered in Hyderabad, India, with its global headquarters in California, USA, currently works with over 70 life sciences organizations across more than 30 countries.

The new center brings together experienced life sciences professionals and AI specialists to ensure that every simulation reflects real-world medical conversations and field conditions. It is designed to continuously enhance SmartWinnr’s AI systems with deep clinical knowledge, therapeutic insights, behavioral science and frontline sales experience. The goal is to build AI that understands the scientific, emotional and ethical dimensions that shape how customer-facing teams engage with healthcare professionals.

The system is trained across two critical dimensions. First, it is coached to think like a healthcare professional by raising authentic questions, objections and concerns that arise in clinical discussions. Second, it is trained to evaluate the performance of medical representatives and deliver clear, actionable feedback that drives measurable improvement. During pilot deployments, customers reported an improvement of 35 percent in representative confidence and 45 percent in message recall.


Keats K Das, Chief of Staff and Director of Sales at SmartWinnr, said in a statement, “We decided to invest in domain-specific AI because that is where meaningful intelligence truly begins. Generic models can simulate conversations, but they cannot fully understand the science, context or compliance responsibilities that define how pharma and medtech teams interact with healthcare professionals. Our goal is to build AI that communicates with accuracy, empathy and regulatory awareness.”

Over the next year, the company plans to scale the center with 20+ additional medical experts and expand coverage across all major therapy areas in life sciences.